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Summary 
3'2b transgenic mice have a severe B cell defect, apparently caused by strong feedback inhibition 
of endogenous H-gene rearrangement  coupled with an inability of 3,2b to provide the survival/matu- 
ration  functions of/~.  A  unique 3,2b transgenic line,  named the C  line,  was found to permit 
B cell development.  When  the C  line is crossed with a #-membrane  knockout line,  3,2b + B 
cells develop in the homozygous knockout.  In contrast,  a transgenic  line representative of all 
the other 3,2b lines is completely B cell deficient when #-mere is deleted. Strikingly,  the C phenotype 
is dominant in C  x  other 72b transgenic line crosses. There is no evidence for higher 3,2b trans- 
gene expression or other position effects on the transgene  in the C  mouse.  The sequences of 
the three 3"2b transgene copies in the C line are identical to that of the original transgene.  These 
results have led to the conclusion that in the C line the transgene integration constitutively in- 
duces a gene whose expression can replace #. To more clearly delineate the stage at which the 
altered phenotype of the C  line is expressed,  C  mice were crossed onto a X5 knockout back- 
ground.  In the absence of ~,5, the C line produces no B cells. Since it was also found that 3'2b 
can associate with the surrogate light chain (sL; h5/Vpre-B),  the crosses between C  line 3'2b 
mice and ~,5 knockout mice suggest that 3"2b/sL is required for B cell maturation in this mouse 
line. Thus, 3'2b alone is unable to replace/~ for pre-B cell survival/maturation;  however, in com- 
bination  with  an unknown  factor and  the sL, 3,2b  can provide these nurturing  functions. 
B  lymphocyte development  is tightly controlled by the 
ability of the maturing pre-B cells to synthesize first heavy 
chains and later light chains (1). Failure to correctly rearrange 
VDJ, at the early pre-B cell stage, or VJ~ or VJ￿  at the late 
pre-B cell stage leads to apoptotic death at the respective stages. 
Normally the functional early heavy chain is #.  Transgenic 
#  as well as/$ have been shown to be able to substitute for 
endogenously produced/~ (for a review see reference 2). These 
transgenes can replace the maturation function as well as the 
heavy chain feedback function of endogenous #.  However, 
3,2b was shown to be unable to substitute for/z (3). Whereas 
transgenic 3,2b causes strong feedback inhibition of endoge- 
nous heavy chain gene rearrangement,  3,2b cannot promote 
B cell maturation,  leading to an arrest at the stage of large, 
B2201~ pre-B cells and a severe B cell depletion (3, 4). Very 
young 3,2b  transgenic  mice have  hardly any B cells in the 
spleen;  at 4 wk of age "~10%  of total spleen lymphocytes 
are B cells, and only after 16 wk of age do the B cell numbers 
reach near normal levels (3). All B cells that do develop ex- 
press endogenous/z. This B cell defect is not due to toxicity 
of 3,2b,  since B cell development proceeds normally when 
the 3,2b mice are crossed with #  transgenic mice (3).  In the 
absence of endogenous/x, 3"2b transgenic mice are absolutely 
B cell depleted as shown in crosses with #-membrane (mere) 
knockout mice (3).  Thus,  apparently 3'2b has the feedback 
function of/~, but not the ability to cause survival/matura- 
tion of pre-B cells. 
These findings were made with four different 72b trans- 
genic lines in our laboratory and apparently are also true for 
3'2b transgenic  mice produced by others  (5,  6),  as well as 
for 3,1 transgenic  mice (7).  However, in the course of our 
studies we observed one unique 3,2b transgenic  mouse line 
whose B cell development appeared normal, except that the 
cells produced essentially no #.  This mouse line is the sub- 
ject of this  report. 
Materials and Methods 
Transgenic Mice.  The 343-1 72b transgenic (Tg[Igh]Bri49) and 
the 243-4/~ transgenic (Tg[Igh]Bri35) lines used as controls have 
been described (8-10). The 348C line (the C line) is derived from 
the 348-4-8 (Tg[Igh]Bri50) line which contained multiple integra- 
tion  sites (3,  10). The #  knockout line was obtained  from  K. 
Rajewsky (Universit~it K61n, K61n, Germany) through C. Sidman 
(University of Cincinnati, Cincinnati, OH) (11). The )x5 knockout 
line was obtained from K. Rajewsky through M. Cooper (Univer- 
sity of Alabama, Birmingham,  AL). 
Flow  Cytometry,  Southern  Blot Analysis,  and RNase  Protection 
Assays.  These were performed  as described in Roth et al.  (3). 
Cosmid Cloning.  High molecular weight DNA was prepared 
from C 3~2b kidney and liver DNA from four transgenic mice. 
Cosmid inserts were generated by DpnII partial digest giving an 
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DNA and  BamHI,  SmaI double-digested cosmid vector c2RB 
DNA (12) were performed overnight at 14~  After packaging, 
the cosmid library was transduced into Escherichia coil strain DH10B 
(Bethesda Research Laboratories, Gaithersburg, MD). Colony lifts 
and hybridization was performed essentially as described (13). Two 
cosmid clones containing  transgene  sequences were  identified. 
The pOOH3 and pOOH6 cosmid clones were mapped  by Southern 
analysis in comparison to genomic DNA from C y2b transgenic 
mice. Subclones were generated by SmaI digestion of the cosmid 
clones and ligation of the Sinai fragments into the EcoRV site of 
BluescriptKS  +  (14). 
DNA Sequencing.  Double strand DNA sequencing was per- 
formed using the Sequenase II kit (United States Biochem. Corp., 
Cleveland, OH). The following primers listed 5' to 3' along the 
3,2b transgene were used: T7 promoter (oTTP20)  and T3 promoter 
(T3) were from New England Biolabs Inc. (Beverly, MA); 5' of 
leader (5L2  =AATACAGCATGCCCACACTGTG);  VH (5'Vy2b = 
GCTGAGCTGATGAGGCCTGGG); VH (VDJ~/2b=TAAAGC  - 
CACACTGACCGCA);  VH 0V300=CAGTAGAGACCGAAC; 
JH2  (3'JH23,2b=CTGAGGAGACTGTGAGAGTG); 3'  of JH2 
(3J2 =AGGGACCTAGCGGCA); 5' of CH1 (SbCHI= CCGAGG- 
CCACTGATAAG); CH1 (G2b-221=GATACACTGGTTCCTCC); 
5'  of Hinge  (5GbH=CCCATACCAGGACAAACTTT);  3'  of 
Hinge (3bH-2=AGGAGCTGATGAGGAGAGATGG);  5' of CH2 
(5CH2=GTCACT ACC AGA GCTCCACT); CH2 (GbCH2= 
TATCAAGGATGTACTCATG); 3'  of CH2 (3CH2=GGCTGA- 
AGTGGAAGGCTGTCC); 3' of CH2 (3CGb2=CTGCTGGTG- 
GCGGCA); 5' of CH (5CH3Gb = CCACTTCAGCCATGACC); 
CH3  (HCH33,2b- 11=TTCTAAGCTTACAGGGCTAGTCAG- 
AGCTCC); CH3 (G2b-1615  =GTTTTCATATIGAGCTIGCTA); 
3' of CH3 (3bCH3=GGATATGGGTGCCAGTGT); 3' of CH3 
(3CGb3=ATGGATAIGGGTGCC); 5' of M1  (53~2b MI=CAG- 
CATCAACCATGTTGGG); 3' of M1 (3bM1-2=AGCAAAGTA- 
ACATCCTACTA); 5' of M2 (SGbM2-2  = CACAGGATTC~AGG- 
GTC); and YUTR (UT-2=GCCTGCTCTGCACATGGTCC). 
Results 
The y2b Transgene of the C Line Permits B Cell Development 
and Suppresses the Synthesis of#.  In other y2b transgenic 
mice a severe depletion of B cells was seen in spleen and other 
lymphoid organs (Table  1 343;  3).  In contrast, the C  line 
has only slightly fewer B cells than normal mice (Table 1). 
The proportion of B220 + or K  + cells is essentially the same 
as in/z transgenic mice, slightly reduced from those in normal 
mice. However, most of the peripheral B cells in the C mouse 
produce  3'2b,  89%  of B220 +  cells  are  "y2b  +,  and  only 
'~17% express #. This is in marked contrast to other ~/2b 
transgenic mice in which every "y2b  + B cell co-expresses/z 
(Table 1; 3). Thus, whereas normally 3'2b does not permit 
B cell development and only few pre-B cells mature (those 
that have managed to rearrange endogenous/~), in the C line 
B cell development proceeds in the absence of/z expression. 
The C'y2b Bone Marrow Contains Maturing B Cells.  Anal- 
ysis of the bone marrow compartment of C ~/2b transgenic 
mice was performed in order to further characterize B cell 
development in these mice (15,  16). 
Adult C bone marrow has reduced numbers of lymphoid 
cells in comparison to normal adult mice. Only 15% of the 
total nucleated cell population in C bone marrow expresses 
B220 in comparison to 26% in normal mice (data not shown). 
However, the distribution and phenotype of cells within the 
lymphoid compartment of C mice is generally normal (Table 
2), although there seems to be a wide variation in the rela- 
tive percentages of cells of a given phenotype. 
Two populations of B220 + ceils  are readily distinguish- 
able within the lymphoid population in normal and C bone 
marrow.  B2201~ cells  constitute 38-60%  of the lymphoid 
population in normal bone marrow in comparison to 18-46% 
Table 1.  Flow Cytometric Analysis of Splenic B Cells from 4-wk-old C "y2b Mice* 
No. of spleen 
Mouse type  ~  /~*  ~/2b  B220  cells ( x 106)s 
Normal n  =  13  56.1  +_  1.8  54.2  _+  2.9  3.05  _+  1.5  64.3  +  2.5  51 (39-90) 
C ~/2b n  =  7  44.7  +  9.1  8.5  _+  4.0  43.7  _+  5.0  48.9  +  10.1  37 (18-50) 
343 3/2bll  11.7  _+  2.7  11.4  +_  2.2  14.5  _+  4.3  26.6  +  1.8  16 (10-27) 
243-4 #  n  --  4  49.8  _+  2.1  28.8  _+  7.4  2.4  +_  0.4  52.6  _+  4.4  42 (31-56) 
(end) 
28.8  +  10.8 
(trg) 
*Spleen cells from  4-wk-old mice were stained for the indicated markers and analyzed  by FACScan  |  A total of 104 lymphocytes  as defined  by for- 
ward and side scatter were analyzed  per sample. The average percentage  of splenic lymphocytes  from 4-wk-old animals positive for the given markers 
is indicated at a 90% confidence  level as determined by t test. 
/z transgenics were analyzed using allotype-specific  antibodies, end, endogenous /zb; trg, transgenic #'. 
S Average number of nucleated cells in the spleen. ( ) Range of values. 
II Data from reference  3. 
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Adult C 72b Mice* 
Mouse 
type  x  #  72b  B220  l~  B220his  h 
% 
Normal  45.3  48.8  3.9  60.4  33.6 
Normal  52.1  59.0  15.3  38.3  41.0 
C 72b  23.8  5.3  28.3  17.9  21.5 
C 72b  51.2  3.2  41.9  34.9  34.5 
C 72b  55.8  1.7  55.7  46.2  43.8 
" Bone marrow from aduh 12-16 wk-old mice was stained for the indi- 
cated markers and analyzed  by FACScan  |  A total of 104 lympbocytes 
as defined  by forward  and side scatter was analyzed  per sample. The per- 
centage of lymphocytes  positive for the given marker is indicated. 
of B220  l~ cells  in  the  lymphoid  population  of C  bone 
marrow (Table 2). B220  hi cells representing more mature B 
cells constitute 34-41% of the lymphoid population in the 
normal bone marrow,  and 22--44%  in C  bone marrow. 
Within the g § population in the bone marrow, immature 
B cells can be distinguished by low B220 expression from 
more mature cells that are B220  hi. FACS  |  analysis (Becton 
Dickinson & Co., Mountain View,  CA) confirmed that all 
the  B220  hi cells  also  express mlg  (data  not  shown).  The 
B220  I~ population consists of both mlg-,  pre-B cells  and 
immature  mlg +,  B  cells.  The  percentage  of g +  cells  is 
similar in normal and C bone marrow (Table 2). In normal 
mice, x + cells express/~, whereas in C  mice, x + cells  are 
72b + and only few express endogenous/z. 
Thus, the C bone marrow contains a relatively normal dis- 
tribution of B cell subpopulations. In addition, the pheno- 
type of the emerging B cells is identical to the B cells ob- 
served  in  the  spleen.  There  does  not  appear  to  be  any 
perturbation in the ability of developing B cells to progress 
through the developmental pathway. This distinguishes the 
C  mice from other "y2b lines which exhibit a block within 
the pre-B cell compartment (3). 
Crosses to a tt 7~ansgenic  Line Reveal that the C Line Is Capable 
oflgM Surface Expression.  C line mice were crossed to a # 
transgenic line in order to determine if the C line has an in- 
herent defect in the ability to express membrane IgM. This 
/x transgenic line exhibits incomplete heavy chain allelic ex- 
clusion (3,  9).  FACS  |  analysis reveals that splenic lympho- 
cytes from C  x  # double transgenic mice coexpress 72b and 
transgenic/x at the cell surface (not shown). The lack of en- 
dogenous/z (/~b) expression of C  mice is maintained in the 
double transgenics  (Table 3). 
The results indicate that C  mice can express high levels 
of mlgM at the cell surface.  Thus, they do not have an in- 
herent defect preventing expression ofmlgM. The C lineage 
seems to be more efficient in promoting heavy chain allelic 
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Table 3.  Flow Cytometric Analysis of Splenic B  Cells from  C 
T2b Crossed to 243-4/2 Mice* 
Mouse 
type  x  #~  /xb~  72b  B220 
4-6 wk 
Normal 
243-4/~ 
C 72b 
C 72b 
￿ 
243-4/~ 
63.3  1.5  53.1  4.4  67.2 
56.0  35.1  41.1  4.6  61.3 
54.6  37.6  36.9  3.5  59.5 
60.4  39.1  42.8  2.7  64.4 
23.4  3.2  12.2  34.8  31.4 
30.3  19.4  10.9  33.9  31.4 
20.7  12.6  6.9  22.9  28.0 
30.5  21.1  7.0  31.8  33.8 
16 wk 
Normal  75.1  2.0  67.5  2.3  82.3 
72.7  3.1  72.1  3.2  78.5 
243-4/x  56.7  34.7  40.6  6.5  62.7 
50.7  35.8  45.6  9.9  68.3 
C 72b  32.5  5.6  7.8  32.3  49.5 
60.8  3.9  2.5  63.9  62.9 
C 72b  40.3  21.0  6.0  27.1  58.1 
￿  38.2  18.8  5.9  30.6  54.6 
243-4 Ix  41.7  19.7  4.7  33.5  59.1 
* Spleen cells from offspring  of C 72b by 243-4/~ crosses were stained 
for the indicated markers and analyzed by FACScan  |  A total of 104 
lymphocytes  as defined  by forward  and side scatter was analyzed  per sam- 
ple. The percentage of splenic lymphocytes  from each animal positive 
for the given marker is indicated. 
* # expression was analyzed using allotype-specific  antibodies. /zb en- 
dogenous ~t; #,, transgenic/z. 
exclusion and development of transgene expressing B cells 
than the 243-4/z lineage. 
Crosses between T2b  Transgenic Lines Reveal Dominance of 
the C  Phenotype.  The C  72b line can efficiently promote 
B cell development and produce peripheral B cells  that do 
not express endogenous/z. In contrast, B cell development 
in the 343-1 and other 72b transgenic lines is dependent upon 
production of a functional/x chain (3). In order to determine 
whether C "y2b transgene expression could functionally sub- 
sl;itute for #  and rescue B cell development in the 343 lin- 
eage,  C  72b mice were crossed with 343 72b mice. 
Analysis  of 4-8-wk-old offspring revealed  that the C  x 
343 double transgenic mice are virtually identical to C-only 
transgenic mice (Fig.  1). Splenic lymphocytes in the C  and 
C  x  343 mice express 72b, but not/~,  on the surface.  In 
contrast, all splenic lymphocytes in 343-only mice express MU  HORMAL 
G2B 
......  id,,  "  .....  i~  ......  '~'  ..... 
i1~  i, 
343  TRAHSGEHIC 
MU 
G2B 
....  ~.~  ......  ~  ....... 
MU  C TRANSGEHIC 
~~  G2B 
C/343  TRAHSGEHIC 
MU 
~~  G2B 
Figure  1.  FACS  |  analysis  of splenic  lymphocytes  from  adult (C x 343 
"r2b) F1 mice. Contour plots depict expression on splenic lymphocytes 
of #-PE staining on the y-axis and ~2b-FITC staining on the x-axis for 
representative  offspring  from a C x 343 "y2b  cross. The genotype  is indi- 
cated within each plot. 
# on the cell surface. In addition, the presence of the C trans- 
gene in C  x  343 double transgenic mice rescues the B cell 
defect characteristic of 343 "/2b mice (not shown). 46-50% 
of splenic lymphocytes in C and C  x  343 mice in this ex- 
periment expressed B220.  Only 33% of splenic lymphocytes 
in 343 mice expressed B220.  In addition, bone marrow from 
C  x  343  double transgenic mice exhibits populations  of 
B220  l~  "y2b  + and B220  hi, "y2b  + cells  similar to those ob- 
served in C mice, but absent in 343 mice (data not shown). 
Thus, the presence of the C ~/2b transgene in 343 trans- 
genic mice can act in a dominant manner to relieve the re- 
quirement for endogenous/~ production. The presence of 
the 343 "y2b transgene copies does not interfere with the gener- 
ation of mature mlg + B cells when an alternative,  functional 
heavy chain is present. 
Expression of'y2b mRNA.  Analysis of C  x  343 double 
transgenic mice indicates that cell surface expression patterns 
of B220 and mlg characteristic of lymphocyte populations 
in C spleen and bone marrow are dominant (see above). In 
addition, we wanted to characterize "y2b transcript levels at 
an early developmental time point  as the C  and 343  lines 
exhibit distinct expression levels at this stage.  The 343 line 
expresses high levels of 3'2b in day 12 fetal liver, whereas the 
C line does not exhibit appreciable 'y2b transcript levels until 
day 14 (14). 
C  x  343  double transgenic embryos express  high levels 
of y2b mRNA in fetal liver at day 12 of development (Fig. 
2). The R.NA expression pattern is identical to that of 343- 
only transgenic embryos: secreted 3,2b mRNA levels exceed 
membrane ~/2b mKNA levels which in turn exceed endoge- 
nous/~ transcript levels. As in previous analyses, C-only em- 
bryos express secreted 72b transcripts at barely detectable levels 
at day 12,  and membrane 3~2b is undetectable at this time. 
Both "y2b transgenic lines, as well as their double transgenic 
offspring express levels of # mRNAs similar to normal mice. 
We presume this to represent mainly sterile #  transcripts, 
but this has not been further investigated. 
Thus, whereas C  ￿  343 double transgenic mice show an 
identical cell surface expression pattern to C  lineage mice, 
embryos exhibit the high 3'2b transcript levels characteristic 
of 343 lineage mice. To determine if in the bone marrow the 
expression of the C  transgene was favored,  bone marrow 
mRNA from normal, conventional ?2b (343),  and C  line 
"y2b transgenic mice was analyzed (Fig. 2, B and C). Results 
very similar to the fetal liver were obtained. The conventional 
"y2b mice produce slightly more 3'2b  mRNA of both the 
membrane and the secreted forms than the C line mice (com- 
pare the y2b bands with the actin bands). In both lines again, 
the secreted form is predominant. These data imply that the 
dominant C  phenotype does not result from higher levels 
of expression of the transgene. Furthermore, the 343  x  C 
crosses show that the high levels of y2b expression in the 
343-1 line are not toxic to B cells. 
The C Line Is Capable of Promoting B Cell Development in 
the Absence of a Functional Endogenous ~  Locus.  To defini- 
tively  determine  whether  C  72b  is  fully  functional  in 
promoting B cell development, the C 3~2b line was crossed 
with mice carrying a homozygous deletion of the/~ mem- 
brane exons (11). The ability of C 3~2b transgenic offspring 
lacking  any  developmentally functional  #  gene  (C  "y2b, 
#rot-/-)  to produce B cells was examined by FACS  |  anal- 
ysis of splenocytes (Fig.  3). Mice of the (C "y2b,/~mt-/-) 
genotype produce "y2b  +  -only B cells as efficiently as C y2b 
littermates carrying one wild-type # locus (C "/2b, #rot+/-). 
Previously, we performed similar crosses between a # knockout 
and a/~ transgenic line (3).  In the absence  of a functional 
endogenous/~ locus,/~ transgenic mice (/~ +,/zmt-/-)  re- 
tain the ability to produce a normal composition of splenic 
lymphocytes (3).  Thus, both #  and C  "y2b transgenes are 
capable  of restoring B cell development in homozygous/~ 
knockout mice, unequivocally demonstrating the ability of 
these transgenes to generate all the required signals for proper 
completion of the B cell developmental pathway. This is in 
striking contrast to other "y2b transgenic lines which have 
a complete inhibition of B cell development in a/~mt-/- 
background (3). 
Cosmid Cloning Reveals that the C Line Contains Three In- 
tact, Wild-type Copies of the 72b Transgene.  The characteris- 
tics of the C 3'2b mice described so far indicate that whereas 
the C line has a dominant ability to promote B cell develop- 
ment, this cannot be explained by a dominant (earlier or 
higher) expression of'y2b in the C line compared with other 
y2b transgenic lines. This implies that the C 3~2b line pos- 
sesses some characteristic fundamentally different from other 
y2b lines. 
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assay  RPA analysis. (A) Day 12 fetal 
liver from C  ￿  343 embryos.  Ap- 
proximately  30/zg of total cellular 
R.NA from individual fetal livers 
was analyzed  by RPA for expression 
of ~2b and/3-actin; the membrane 
and secreted specific forms of the 
~,2b are indicated;  each  lane  contains 
RNA from an individual  fetal  liver 
with the indicated genotype. The 
samples in the right panel  were  also 
analyzed for  #  expression. The 
J558L~2b lane represents control 
RNA from a myeloma  line trans- 
fected  with the linearized  "y2b  trans- 
gene and expresses predominantly 
secreted  3~2b (10). Ig05  is transfected 
with an altered  3'2b gene  that pro- 
duces  predominantly membrane 
y2b (44). The actin lane (act) con- 
tains fetal  liver  RNA hybridized  to 
only the/3-actin probe. (B) Bone 
marrow from normal mice and C- 
y2b transgenic mice, and, as con- 
trols,  cell lines  as  indicated: 
J558Lq~2b and Ig05 are as in A; 
70Z/~4  is a transfectant  of  the 70Z/3 
late pre-B  cell  line  with the VH167# 
transgene; it expresses  equal  levels of 
membrane  and secreted/z.  (C) Bone 
marrow from normal and conven- 
tional "y2b  (343)  transgenic mice. 
It was possible that a transgene copy in the C line could 
have sustained a mutation changing the structure and func- 
tion of the transgene product to become functionally like 
#. In the course of the analysis of other independent trans- 
genic lines we have found evidence for point mutations and 
short deletions that likely had occurred before transgene in- 
tegration (17,  18). 
Thus,  the transgenes of the C  line were cloned in order 
to determine if the sequences had been altered. From the ini- 
tial characterization of the C  line we knew that no major 
deletions or structural alterations had occurred during trans- 
gene integration (14). An integration site map was developed 
to facilitate identification of  each of the three transgene copies. 
The integration site analysis confirmed the copy number to 
be precisely three in the C 3'2b lineage, organized as a con- 
secutive array with each copy in the same orientation (14). 
The map revealed  that  the three transgene copies differ at 
the extreme 5' ends and that two of the copies have incurred 
small deletions of polylinker sequence. These deletions are 
minor and do not extend into regulatory or coding regions 
of the transgene.  There is no evidence for deletion of any 
transgene sequence at  the 3' end of any of the copies. 
Two overlapping cosmid clones (pOOH3 and pOOH6) 
containing the entire C  transgene array,  as well as pieces of 
flanking DNA from either side of the locus, were isolated 
(Fig. 4). Their integrity was confirmed by Southern analysis 
compared with genomic DNA from C transgenic mice (not 
shown).  The pOOH6 cosmid contains all  three transgene 
copies  and  "~3  kb  of 5'  flanking  DNA  and  that  of the 
pOOH3 cosmid contains '~15 kb of 3' flanking DNA,  the 
3' transgene copy and part of the middle transgene copy ex- 
tending to a BamHI site in the CH1 domain of the constant 
region (Fig.  4). 
Individual transgene copies were subcloned and each sub- 
clone containing a specific region of the C  transgene array 
was subjected to sequence analysis. The entire coding region 
sequence of each transgene copy was determined, as well as 
splice donor and splice acceptor sequences at the borders of 
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Figure  3.  FACS  |  analysis  of 
spleen  from  C  "~2b transgenic 
mice  x  /~ knockout mice. Plots 
depict expression on splenic lym- 
phocytes of #-PE on they-axis and 
￿9  y2b-FITC  on the x-axis. (+/-) 
Wild-type or disrupted,  respec- 
tively, # locus in "y2b transgenic 
or normal littermates  (NML). 
each exon, and its respective introns and compared to the 
published sequence for the BALB/c "y2b locus and the original 
transgene (not shown) (10, 19). 
Several nudeotide substitutions, deletions, and additions 
were identified in the variable region of all three transgene 
copies (not shown, but these sequence data are available from 
EMBL/GenBank/DDBJ under accession number M21294). 
These nucleotide changes result in alteration of the leader 
and V  region sequence predicted by Tsang et al.  (10). All 
the nucleotide changes were found to be present in the "y2b 
plasmid used to create these lines. In addition, sequence anal- 
ysis of a portion of the variable region DNA from the 343-1 
3~2b line confirmed the presence of these mutations. Thus, 
it seems that all the nucleotide changes observed by sequence 
analysis of the C  transgene copies are accountable as errors 
in the published sequences. 
The cosmid analysis conclusively demonstrates that the C 
y2b lineage contains three intact and wild-type "y2b trans- 
gene copies. Thus the structure of the "y2b transgene product 
expressed from the C locus cannot be responsible for the unique 
phenotype that characterizes  the C  "y2b lineage.  This sug- 
gests that the integration site may influence the generation 
of the C-specific phenotype. 
Crossing the C Line "y2b Transgene into a A5 Knockout Back- 
ground Eliminates B Cell Development.  Given that the C line 
can promote B cell development independent of #, it appeared 
possible that the 3'2b transgene was integrated near and acti- 
vated a locus which normally was expressed after signaling 
via the pre-B cell receptor/~/surrogate light chain (sL)L Pos- 
sible candidate genes could be kinases or other molecules in- 
volved in the signaling cascade, perhaps acting independently 
of the requirement for a functional pre-B cell receptor.  To 
evaluate if a pre-B cell receptor was required for B cell devel- 
opment in the C line, we crossed the 'y2b transgene of the 
C line (and as a control of the 343-1 'T2b line [3]) with mice 
whose )x5 locus was inactivated by homologous recombina- 
tion (20). 
The results clearly show that no B calls develop in the C 
transgenic line when X5 is not expressed (Fig. 5). The B cell 
1  Abbreviation used in this paper: sL, surrogate  light chain. 
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Figure  4.  Schematic representation  of transgene  orientation and 5' end configuration  in the C T2b line. The three transgenes in the C line are in 
the same orientation and each contains  the indicated  unique 5' end structure.  (Solid boxes) Exons; (filled ovals) the heavy chain enhancer  present in 
each copy; and (stippled boxes) the pUC13 vector sequence remaining  on the ends of the copies. The region contained  within each isolated cosmid 
clone is indicated below. (Sph) SphI; (Nco) NcoI; (Barn) BamH1; (Xba) XbaI; (Eco) EcoRI; (Kpn) KpnI; and (Sma) Smal. 
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gene are the same regardless of the presence of the C- or the 
343-1 3~2b transgenes. Both show essentially no B cells. This 
suggests that 3/2b in combination with the sL (XS/Vpre-B) 
is required for B  cell development  in  the C  mouse. 
Normally early pre-B cells do not express 3'2b. The ability 
of this heavy chain to associate with ~,5 and Vpre-B was as- 
sessed by transfecting  the transgene into the pre-B cell line 
70Z/3  that  expresses the sL.  Immunoprecipitation  of "~2b 
from 3SS-methionine-labeled cells reveals coprecipitation of 
two proteins with the expected mobility of the sL X5 and 
Vpre-B (not shown). In addition,  LPS stimulation of these 
cells results in replacement of the sL by conventional light 
chain  once  K expression  is  induced  (Roth,  P.  E.,  and  A. 
DeFranco, unpublished results). Thus ~2b heavy chains can 
physically associate with sL to form a pre-B cell receptor and 
expression of this receptor is required for complete B cell de- 
velopment in the C  line of y2b transgenic  mice. 
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Figure  5.  FACS  |  analysis  of 
spleen from C "/2b transgenic x ;~5 
knockout mice. Spleens  from 4-wk- 
old heterozygous  (+/-) and homo- 
zygous (-/-)  mice were stained 
with PE-conjugated  anti-g antibody 
and FITC-conjugated  anti-B220  an- 
tibody. The percentages of cells in 
the R2 window  were:  (NORMAL 
-/-)  2.9%; (NORMAL  +/-) 
33.1%;  (343  -/-)  0.6%; (343 
+/-)  1.8%; (348C  -/-)  1.4%; 
and (348C  +/-)  10.8%. The R2 
gatings for the 348C mice differ 
slightly from the others as they  were 
done in a separate experiment. NORMAL 
TRANSGENIC ~2b IN  B CELL DEVELOPMENT 
DroB  early  DreB  late  DreB 
DJ  ......... >VDJCI~ 
-->  Inhibit|  further 
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B 
~+  B  cells 
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Figure 6.  Model  for B cell  development  in two types 
of ~/2b transgenic mice. The model outlines the inhi- 
bition of Ig gene rearrangement mediated by ~'2b 
during the pro-B through early pre-B cell stages. The 
activation of an endogenous  gene due to transgene in- 
tegration in the C mouse results in the maturation 
or survival of pre-B cells which can then continue 
through the complete  developmental  pathway to give 
rise to mature splenic lymphocytes  expressing only  5,2b 
heavy chains. In other "y2b  transgenic mice only rare 
pre-B cells  correctly  rearrange an endogenous  VDJCp. 
gene before  feedback  inhibition by the y2b transgene. 
Discussion 
This paper reports the analysis of a unique 3'2b transgenic 
mouse that has essentially normal B cell development, in con- 
trast to all other 3'2b transgenic mice (3-6) (Fig. 6). The C 
line is, however, similar to other "/2b transgenic lines in that 
the "y2b transgene is expressed in fetal liver,  bone marrow, 
and the spleen, and it causes feedback inhibition  of endoge- 
nous heavy chain gene rearrangement. 
"y2b Transgenes  Promote  Allelic Exclusion of  Endogenous Heavy 
Chains.  All y2b transgenic mice analyzed by us exhibit strong 
allelic exclusion of endogenous heavy chains (3; this paper). 
This seems also to be the case for y2b transgenic  mice reported 
by others  (5,  6).  The findings  with  the C  mouse support 
this conclusion: most B cells express 3~2b only, and in crosses 
with  a #  transgenic  mouse,  the expression of endogenous 
/~ chains is  suppressed much more strongly than  in the 
transgehic mice without the 3'2b transgene (Table 3). Thus, 
the ability for heavy chain gene feedback is shared by/z, 6 
(21), and 3'2b. These three isotypes are closely related in their 
transmembrane  domain and it is possible that the feedback 
requires that domain. Replacing the transmembrane domain 
of a "y2b transgene with that of/~ still permits the feedback 
inhibition, but does not restore the B cell maturation defect 
of y2b mice (3). 
B Cell Development Is Similar in C T2b Transgenic Mice to 
/~ Transgenic Mice.  B cells expressing mlg accumulate some- 
what more slowly in C transgenic mice than in normal mice. 
This is similar to the reduction seen in the 243-4 #  trans- 
genic line examined in comparison  to the C  line (Table  1). 
Other studies (22-25) have also shown that Ig transgenic  mice 
exhibit a reduction in the size of their B cell population,  al- 
though the severity of the depletion varies.  In addition  to 
the variability in B cell populations between different trans- 
genic lines, there is variability in the level of feedback regula- 
tion resulting in allelic exclusion in different transgenic lines. 
The C line exhibits stronger allelic exclusion than the 243-4 
# line (Table 3). However other/z transgenic lines have been 
shown to exhibit a similar degree of allelic exclusion as the 
C  line (26,  27). 
A large proportion of y2b/v double-producing B cells is 
seen in the spleen of/~-  x  3,2b-transgenic crosses.  This sug- 
gests that  selection against cells which produce two heavy 
chains is not automatic.  (It may of course play a role in antigen- 
specific tolerance). Furthermore, feedback inhibition of H-gene 
rearrangement by "y2b heavy chains clearly is very significant 
(Table 3). Taken  together,  these results further  support the 
existence of heavy chain feedback, rather than  selection, as 
the major mechanism for heavy chain allelic exclusion (28). 
Why  is  the  C  Mouse Able  to  Promote B  Cell Develop- 
ment?  The findings presented here show that the C line differs 
from all other ~2b transgenic lines (3-6) in its permissive- 
ness orB cell development. Most B cells in the C line express 
y2b only, the C  line transgene can rescue the B cell defect 
of another  3'2b transgenic  line,  and C  line B cells develop 
in the absence of/z expression in a/z knockout background. 
What is the molecular basis for the unique phenotype in 
the C y2b transgenic line? Below we summarize the mecha- 
nisms by which the 3~2b transgene in the C line could affect 
B cell development. An important basis for our conclusions 
is the dominance of the C phenotype in crosses with another 
3~2b transgenic  line. 
(a)  It is unlikely that  the C  effect is due to inactivation 
of an endogenous gene, since the effect is dominant. The trans- 
gene has been carried as a hemizygous integration for many 
years,  thus a normal locus would always be present.  The C 
phenotype is also independent of the sex of the parent trans- 
mitting the transgene,  indicating that the normal locus cannot 
be inactivated by parental  imprinting. 
(b) The integration of the y2b transgene in the C line does 
not qualitatively nor quantitatively change the expression of 
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can explain the phenotypic differences.  Since the C  pheno- 
type is dominant, a position effect would have to express it- 
self in a positive way, such as earlier or stronger expression 
or an increase in the membrane form of the 3~2b mRNA. 
Comparing 3r2b expression in transgenic lines shows that the 
expression of 3'2b is somewhat weaker and slightly delayed 
in the C line (Fig.  3). Furthermore, the ratio of membrane 
to secreted 3'2b mRNA is shifted in favor of the secreted form 
in both lines of 3r2b transgenic mice (Fig. 3). Finally, in crosses 
between the C  and 343-1 3~2b transgenic lines,  the mRNA 
profile of the double transgenic is identical to that of the con- 
ventional 3'2b  line (343), whereas B cell development pro- 
ceeds identically to the C  line. 
Furthermore, different 3'2b  transgenics express different 
levels of 'y2b (3).  The expression in the C  mouse seems to 
be between the two extremes, the 343  and 348A mice, in 
level and timing. The 343 mice have the strongest feedback 
effect and the lowest number of B cells in young mice, whereas 
the 348A mice have the least feedback and the highest number 
of B cells.  Nevertheless, both 343  and 348A express/x on 
all B cells, in marked contrast to the C line.  It appears  thus 
very unlikely that the expression pattern of the 'y2b trans- 
gene itself is responsible for the B cell developmental effect 
seen in the C  line. 
(c) A  third possibility seemed that the transgene in the 
C line might be altered in a way that would allow it to mimic 
/x during B cell development. However, as shown, the three 
transgene copies in the C  line are identical to those in the 
other three 3'2b transgenic lines produced in our laboratory 
(3,  10). 
(d) This leaves the possibility that the transgene integra- 
tion site itself mediates the phenotype observed in the C line. 
Transgene expression is regulated by the strong heavy chain 
intronic enhancer. Essentially all transgenic mice with trans- 
genes regulated by this enhancer express the transgene regard- 
less of chromosomal integration site (2).  It is possible that 
an endogenous locus is coordinately activated with the "y2b 
transgene due to the insertion of the heavy chain enhancer. 
This is analogous to B cell neoplasias  associated  with trans- 
location or mutation events resulting in alterations in expres- 
sion patterns of normal cellular genes (29). 
Since the original  founder mouse was  a  (C57BL/6  x 
SJL)Fz, the possibility existed that  the transgene in the C 
mouse was integrated in a SJL-derived chromosome retained 
despite the backcrossing to C57BL/6.  The difference to the 
conventional transgenics could have been due to maintenance 
of this SJL component in the C mouse. However, crossing 
of the conventional 3'2b  mouse lines,  343  and 348A, with 
SJL did not result in a C phenotype (Kurtz, B., and U. Storb, 
unpublished observations). 
One of the functions of/x appears  to be the upregulation 
of light chain gene rearrangement in pre-B cells,  although 
a basal level of light chain rearrangement does not require 
/z (20, 30-32). We previously investigated the possibility that 
y2b was unable to upregulate light chains. That analysis in- 
dicated that the B cell defect observed in 3'2b transgenic mice 
was not alleviated when the 343-1 3'2b line was crossed with 
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a )x transgenic line (3).  The )~ transgene in that analysis is 
regulated by the heavy chain enhancer and should therefore 
be expressed early enough to provide high levels of light chains 
(33). Furthermore, in fetal liver and bone marrow of the 343-1 
3'2b line, the levels of endogenous r  mKNA appear to be 
normal (3).  In the C line too, there does not appear to be 
any change in the timing or level of expression of endoge- 
nous r  (14). Additionally, we have localized the integration 
site of the transgene to chromosome 13 (Kurtz, B., A. Fer- 
nald, M. LeBean, and U. Storb, unpublished results), thus 
it cannot directly affect either r (chromosome 6) or X (chro- 
mosome 16) light chain genes. Taken together, these results 
make it unlikely that the phenotype in the C line results from 
transgene insertion activating either of the endogenous light 
chain loci. 
The Requirement for It May be Circumvented in the C y2b 
Transgenic Line by Intersection of Signaling Pathways.  Since all 
other possibilities  appear unlikely, we postulate that a pro- 
tein, which is not a light chain, is produced in the C line, 
and that expression of this protein during B cell development 
can overcome the block normally seen in 3'2b transgenic mice. 
This protein would presumably be produced by a gene acti- 
vated by the heavy chain enhancer in the transgene. Since 
#  is not required for B cell development in the C line, pre- 
sumably a signal must be generated that circumvents/z. The 
signals generated by # apparently operate through the pre-B 
cell receptor in combination with the sL, X5 and Vpre-B (16, 
20).  Thus, circumventing the signal could occur at several 
levels, namely, the pre-B cell receptor itself, a ligand for the 
receptor, or a downstream event within the signaling cas- 
cade of the pre-B cell receptor. However, a downstream event 
could not act autonomously, since the crosses with the X5 
knockout mice indicate that signaling through a pre-B cell 
receptor is required for B cell development in the C line. Un- 
less X5 has an as yet unknown function, that is independent 
of the pre-B cell receptor, the lack of B cells in the X5 knockout 
mice that carry the C "/2b transgene suggests that 3'2b has 
a signaling role in B cell development in the C line and that 
3'2b functions in association with X5. Consistent with this 
is the finding that the ~/2b heavy chain expressed in these 
transgenic mice can associate with the X5 and Vpre-B chains 
when transfected into a sL positive cell line. 
Why, if a sL complex is required for B cell development 
in the C line, do other y2b transgenes not promote develop- 
ment? Apparently, a 3,2b/sL receptor is not sufficient to drive 
B cell development (Fig.  7).  An additional function is re- 
quired and the C 3'2b line is unique among 3'2b transgenic 
lines in being able to provide this signal. The postulated gene 
activated in the C line is unlikely to participate in an event 
upstream to the expression of 3'2bAL since B cell develop- 
ment arrests at the same (3, 20) or slightly later (Kurtz, B., 
and U. Storb, unpublished observations) pre-B cell stage in 
conventional  3'2b  transgenic  lines  compared  to  the  X5 
knockout mice. Thus the function of the unknown gene in 
the C  line is either coincident with the 3'2b/sL  signal,  or 
is a downstream event induced by the y2b/sL signal. 
A complex signal may be generated by the/z/sL, but only 
a partial signal by the y2bAL. Indeed, #, in association with A  model of B-cell development in the C  line 
Most v2b  C  ,t2b 
Normal  Transgonlcs  Transgonlcs 
./sL  /  !  Blod(~ r~t.~ion 
! 
# 
o 
o 
No  M~"ur'~n  Maturation 
Figure 7.  Scheme  of signaling via different pre-B cell receptors. An un- 
known factor makes a "y2b/sL receptor signal functionally  equivalent to 
a #/sL receptor signal. 
conventional light chain, has been shown to mediate a mul- 
titude of signals upon activation of the B cell antigen receptor 
(for a review see reference 34). In the C line, a protein may 
be recruited which in combination with the 3,2b/sL receptor, 
results in signals indistinguishable from those generated by 
/zAL. Since double transgenic mice with the C  3/2b and # 
transgenes have normal B cell development and express/z, 
if such a protein is present, it may not interfere with pre-B 
cell receptor signaling via #/sL. 
Another possibility for the postulated gene product acti- 
vated in the C line may be a ligand for the 3,2b/sL receptor. 
This could be either a molecule present in other cells in the 
bone marrow or a protein induced within the pre-B cell after 
receptor assembly. Other cells interacting with pre-B cells 
that could express the qr2b/sL receptor ligand could be stromal 
or T cells. However, the effect is unlikely to be due to stromal 
cells since the C phenotype can be adoptively transferred to 
irradiated  mice (Roth,  P.  E.,  and  U.  Storb,  unpublished 
results).  The bone marrow recipients produce "y2b-only B 
cells and it is not likely that stromal cells have been preserved 
in the transferred cells. 
T  cells,  however, could express the postulated gene acti- 
vated in the C  line. T  cells are known to transcribe heavy 
chain transgenes under the control of the heavy chain intronic 
enhancer (2). However, T  cells are apparently not required 
for normal B cell development since introduction of trans- 
genic heavy and light chain genes into recombination activating 
gene (RAG) knockout mice, which lack T cells, is sufficient 
to allow B cell development (35, 36). Expression of different 
factors can influence pre-B cell growth and differentiation, 
thus it remains a formal possibility that a gene functioning 
in T cells could be activated in the C line to promote B cell 
development. 
An additional possibility is that the postulated gene is ex- 
pressed within pre-B cells in a post pre-B cell receptor func- 
tion. As discussed, it seems likely that the 3,2bAL receptor 
provides only a subset of the signals generated by a ~AL 
receptor. Thus, activation ofa gene that is normally a down- 
stream target of pre-B cell receptor signaling could compen- 
sate for the missing signal. It is also possible that the acti- 
vated  gene  does  not  normally  function  during  B  cell 
development, but can substitute for the missing signal when 
ectopically expressed. Indeed, functional redundancy has been 
demonstrated in TCR signaling. For example, increased ex- 
pression of either the T  cell-specific isoform of p59f~, (fyn 
T), or the alternative isoform prevalent in brain, (fyn B), results 
in improved responsiveness to TCR stimulation demonstrating 
that fyn  B can substitute for fyn T  (37). 
Finally, another potential function of the postulated gene 
activation event in the C  line could be to promote cell sur- 
vival. Genes such as Bcl-2, can promote cell survival and block 
induction of apoptosis  (38--40).  In  addition, Bcl-2 and its 
partner, Bcl-x, do not reside on chromosome 13 (the site of 
the C transgene integration), but on chromosome I (41) and 
2  (Thompson, C.,  personal communication), respectively, 
making it unlikely that these genes are specifically involved 
in mediating B cell development in the C  line.  It remains 
possible that as yet unknown genes can mediate pre-B cell 
survival. Perhaps one of the functions of signaling through 
the pre-B cell receptor is to induce cell survival or progres- 
sion through the cell cycle to expand developing pre-B cells 
with functional heavy chain gene rearrangements. Developing 
pre-B cells have a finite life span and in the absence of appro- 
priate signals it is likely that these cells apoptose in the bone 
marrow (42, 43). A failure of ~/2b to promote cell survival 
is consistent with the severe B cell defect observed in most 
3'2b transgenic mice (3). Thus, activation of a gene involved 
in cell survival or cell cycle progression could mediate the 
phenotype characteristic of the C line. It is important to note 
however, that signaling through the qr2bAL receptor is re- 
quired either to activate this gene or in addition to activation 
of this gene to render the cells  susceptible to its activity. 
In summary, we present the characterization of a unique 
"y2b transgenic line. Unlike all other "r2b transgenic lines, 
the C line produces B cells expressing only 3'2b heavy chains. 
We have shown that this phenotype is mediated neither by 
a unique expression pattern of the C  transgene, nor by an 
alteration of the transgene itself. We postulate instead that 
'y2b, in combination with the sL and an unknown factor, 
can replace/~ in B cell development (Fig. 7). The precise mech- 
anism promoting B cell development in this unique line has 
not been fully elucidated. We offer several possibilities for 
functions that could be activated in the C line. Most of these 
possibilities can be tested experimentally. These studies reiterate 
the complexity of requirements for proper B cell develop- 
ment. The production of a functional heavy chain mediates 
progression through the developmental pathway, but it is clear 
from these studies that multiple signals are required to com- 
plete this pathway. It is hoped that this unique line will lead 
to new insights into the signals necessary for B cell devel- 
opment. 
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